CAS 116371-66-5
:Citosina 5'-(trihidrogênio difosfato), 2'-desoxi-2',2'-difluoro-
Gemcitabine Diphosphate Ditetrabutylammonium Salt
CAS:Fórmula:C9H11F2N3O10P2·2C16H36NPeso molecular:421.14 2*242.47Gemcitabine Diphosphate Triethylamine Salt (>90%)
CAS:Produto ControladoApplications Gemcitabine Diphosphate is a phosphorylated metabolite of Gemcitabine (G305000), an antineoplastic agent.
References Baker, C., et al.: J. Med. Chem., 34, 1879 (1991), Huang, P., et al.: Cancer Res., 51, 6110 (1991), Plunkett, W., et al.: Nucleosides Nucleotides, 16, 1261 (1997),Fórmula:C27H58F2N6O10P2Pureza:>90%Cor e Forma:White To Off-WhitePeso molecular:726.73Gemcitabine diphosphate triethylamine salt
CAS:Gemcitabine diphosphate triethylamine salt is an inhibitor that has been shown to be effective in the treatment of various forms of cancer. It works by inhibiting the activity of kinases, which are enzymes involved in the regulation of cell growth and division. Gemcitabine diphosphate triethylamine salt is a prodrug that is converted to its active form, gemcitabine, in vivo. This drug has been shown to inhibit the uptake of xylose by cancer cells, leading to decreased protein synthesis and induction of apoptosis. In addition, it has been found to be effective against human and Chinese medicinal tumor cells. Gemcitabine diphosphate triethylamine salt is a promising treatment option for patients with cancer who have not responded well to traditional chemotherapy or radiation therapy.
Fórmula:C9H13F2N3O10P2Pureza:Min. 95%Peso molecular:423.16 g/molRef: ST-EA-CP-G7026
Produto descontinuado



